Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_1
3
60%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
66.7%
Most Advanced
Phase 1

Trials by Phase

Phase 13 (60.0%)
N/A2 (40.0%)

Trials by Status

terminated120%
active_not_recruiting120%
completed240%
recruiting120%

Recent Activity

2 active trials
Showing 5 of 5
completednot_applicable

Comparison of Combination of Itraconazole and Isotretinoin Versus Itraconazole Alone in the Treatment of Resistant Trichophyton Infection

NCT07420894
active_not_recruitingphase_1

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

NCT06084481
terminatedphase_1

A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088

NCT06579300
recruitingnot_applicable

Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children

NCT07184203
completedphase_1

A Study to Assess Change in How Oral Icalcaprant With Itraconazole Moves Through the Body in Healthy Adult Participants

NCT06722430

Clinical Trials (5)

Showing 5 of 5 trials
NCT07420894Not Applicable

Comparison of Combination of Itraconazole and Isotretinoin Versus Itraconazole Alone in the Treatment of Resistant Trichophyton Infection

Completed
NCT06084481Phase 1

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

Active Not Recruiting
NCT06579300Phase 1

A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088

Terminated
NCT07184203Not Applicable

Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children

Recruiting
NCT06722430Phase 1

A Study to Assess Change in How Oral Icalcaprant With Itraconazole Moves Through the Body in Healthy Adult Participants

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5